AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 83 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,386,000 | -76.4% | 22,905 | -34.3% | 0.00% | – |
| Q2 2022 | $5,861,000 | -27.7% | 34,885 | +102.3% | 0.00% | – |
| Q1 2022 | $8,103,000 | -65.8% | 17,241 | -58.5% | 0.00% | – |
| Q4 2021 | $23,665,000 | -59.2% | 41,517 | +18.9% | 0.00% | – |
| Q3 2021 | $57,954,000 | +373.7% | 34,912 | +376.5% | 0.00% | – |
| Q2 2021 | $12,234,000 | +11663.5% | 7,326 | +4367.1% | 0.00% | – |
| Q2 2020 | $104,000 | -63.5% | 164 | -76.1% | 0.00% | – |
| Q1 2020 | $285,000 | -28.8% | 686 | 0.0% | 0.00% | – |
| Q4 2019 | $400,000 | -93.5% | 686 | -94.4% | 0.00% | – |
| Q3 2019 | $6,127,000 | +29.2% | 12,228 | 0.0% | 0.00% | – |
| Q2 2019 | $4,742,000 | -67.5% | 12,228 | -52.9% | 0.00% | – |
| Q1 2019 | $14,581,000 | +1870.4% | 25,945 | +1283.7% | 0.00% | – |
| Q4 2018 | $740,000 | -43.8% | 1,875 | -27.7% | 0.00% | – |
| Q3 2018 | $1,317,000 | -77.1% | 2,593 | -1.0% | 0.00% | – |
| Q2 2018 | $5,760,000 | +6676.5% | 2,618 | +10372.0% | 0.00% | – |
| Q1 2018 | $85,000 | -16.7% | 25 | 0.0% | 0.00% | – |
| Q4 2017 | $102,000 | +580.0% | 25 | 0.0% | 0.00% | – |
| Q3 2017 | $15,000 | +15.4% | 25 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | -97.6% | 25 | -96.3% | 0.00% | – |
| Q1 2017 | $540,000 | -48.6% | 675 | -42.2% | 0.00% | – |
| Q4 2016 | $1,051,000 | -63.4% | 1,168 | -69.9% | 0.00% | – |
| Q3 2016 | $2,873,000 | +28.2% | 3,882 | +123.5% | 0.00% | – |
| Q2 2016 | $2,241,000 | -69.2% | 1,737 | +80.0% | 0.00% | – |
| Q1 2015 | $7,266,000 | -17.7% | 965 | -61.4% | 0.00% | – |
| Q3 2014 | $8,829,000 | +185.0% | 2,501 | +574.1% | 0.00% | – |
| Q2 2014 | $3,098,000 | -50.7% | 371 | -64.1% | 0.00% | – |
| Q1 2014 | $6,285,000 | -33.6% | 1,032 | -22.2% | 0.00% | – |
| Q4 2013 | $9,462,000 | -86.0% | 1,327 | -88.7% | 0.00% | – |
| Q2 2013 | $67,613,000 | – | 11,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|